The M694V variant of the familial Mediterranean fever gene is associated with sporadic early-onset Alzheimer's disease in an Italian population sample

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 1, 2006, Pages 55-59

  Arra, Mariarosa ^a   Emanuele, Enzo ^a   Martinelli, Valentina ^a   Minoretti, Piercarlo ^a   Bertona, Marco ^a   Geroldi, Diego ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alzheimer's disease, age at onset; Pyrin, single nucleotide polymorphism

Indexed keywords

AMINO ACID;

AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; ONSET AGE; PRIORITY JOURNAL; PYRIN GENE; RISK ASSESSMENT; WILD TYPE;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; COMORBIDITY; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENOTYPE; HUMANS; INCIDENCE; ITALY; MALE; POINT MUTATION; SURVIVAL RATE;

EID: 33845730360     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096743     Document Type: Article

References (32)

1. St George-Hyslop PH, Petit A: Molecular biology and genetics of Alzheimer's disease. C R Biol 2005;328:119-130.
2. Imbimbo BP, Lombard J, Pomara N: Pathophysiology of Alzheimer's disease. Neuroimaging Clin North Am 2005;15:727-753.
3. Heese K, Akatsu H: Alzheimer's disease - An interactive perspective. Curr Alzheimer Res 2006;3:109-121.
4. Mahley RW, Weisgraber KH, Huang Y: Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006;103:5644-5651.
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
6. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC, Cache County Study Investigators: Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Arch Gen Psychiatry 2004;61:518-524.
7. Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P: Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med 2000;132:533-537.
8. Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, D'Angelo A, Montagna L, Bruni AC, Geroldi D: Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease. Neurosci Lett 2004;357:45-48.
9. Hull M, Lieb K, Fiebich BL: Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs. Curr Med Chem 2002;9:83-88.
10. Walsh S, Aisen PS: Inflammatory processes and Alzheimer's disease. Expert Rev Neurother 2004;4:793-798.
11. Aisen PS: Inflammation and Alzheimer disease. Mol Chem Neuropathol 1996;28:83-88.
12. Schaner PE, Gumucio DL: Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways. Curr Drug Targets Inflamm Allergy 2005;4:67-76.
13. Onen F: Familial Mediterranean fever. Rheumatol Int 2006;26:489-496.
14. Mott RT, Hulette CM: Neuropathology of Alzheimer's disease. Neuroimag Clin North Am 2005;15:755-765.
15. Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, Bar-Meir S, Avidan B, Shinhar Y: The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease. Am J Gastroenterol 2005;100:338-343.
16. Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, Shinar Y: Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005;64:1009-1014.
17. Grimaldi MP, Candore G, Vasto S, Caruso M, Caimi G, Hoffmann E, Colonna-Romano G, Lio D, Shinar Y, Franceschi C, Caruso C: Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol 2006;79:611-615.
18. Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E, Reino M, Geroldi D: Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 2006;391:147-149.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
20. 2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians. Neurosci Lett 2005;386:176-178.
21. Milledge J, Shaw PJ, Mansour A, Williamson S, Bennetts B, Roscioli T, Curtin J, Christodoulou J: Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood 2002;100:774-777.
22. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
23. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES: The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002;277:21119-21122.
24. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL: Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003;11:591-604.
25. 1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol 2000;103:97-102.
26. Griffin WS, Mrak RE: Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 2002;72:233-238.
27. Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, Gavazzi A, Calabrese E, Martinelli Boneschi F, Sorbi S, Mariani C, Franceschi M, Grimaldi LM: Interleukin-1β polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging 2003;24:927-931.
28. de la Torre JC: Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152-1162.
29. de la Torre JC: Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 2004;26:517-524.
30. Holmans P, Hamshere M, Hollingworth P, Rice F, Tunstall N, Jones S, Moore P, Wavrant DeVrieze F, Myers A, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J, Ramic D, Williams N, Norton N, Abraham R, Kehoe P, Williams H, Rudrasingham V, O'Donovan M, Jones L, Hardy J, Goate A, Lovestone S, Owen M, Williams J: Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2005;135:24-32.
31. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA Jr, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA: Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 2002;70:985-993.
32. Lio D, Annoni G, Licastro F, Crivello A, Forte GI, Scola L, Colonna-Romano G, Candore G, Arosio B, Galimberti L, Vergani C, Caruso C: Tumor necrosis factor α -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev 2006;127:567-571.